India's top court dismisses Novartis petition for Glivec patent

NEW DELHI (Reuters) - India's highest court has dismissed Swiss drugmaker Novartis AG's petition seeking patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms which are increasingly focusing on India to drive sales.

via Reuters: Health News Read More Here..